A Randomized, Open-label, Comparative, Non-inferiority, Multicenter Study to Compare Efficacy of Losartan Potassium Group and Carvedilol Group on Arterial Stiffness in Essential Hypertension Patients.

Trial Profile

A Randomized, Open-label, Comparative, Non-inferiority, Multicenter Study to Compare Efficacy of Losartan Potassium Group and Carvedilol Group on Arterial Stiffness in Essential Hypertension Patients.

Completed
Phase of Trial: Phase IV

Latest Information Update: 07 May 2017

At a glance

  • Drugs Losartan (Primary) ; Losartan/hydrochlorothiazide (Primary) ; Carvedilol; Hydrochlorothiazide
  • Indications Essential hypertension
  • Focus Therapeutic Use
  • Acronyms LAAS
  • Sponsors Merck Sharp & Dohme
  • Most Recent Events

    • 10 Nov 2009 Actual end date (Sep 2009) added as reported by ClinicalTrials.gov.
    • 10 Nov 2009 Actual end date (Sep 2009) added as reported by ClinicalTrials.gov.
    • 10 Nov 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top